Tenor Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Tenor Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-250,000	Closed	-$2.61M	–	487
2023 Q1	$2.61M	Hold	250,000	–	–	0.05%	161
2022 Q4	$2.55M	Hold	250,000	–	–	0.06%	195
2022 Q3	$2.51M	Hold	250,000	–	–	0.06%	242
2022 Q2	$2.49M	Hold	250,000	–	–	0.06%	254
2022 Q1	$2.5M	Buy	+250,000	New	+$2.48M	0.05%	251

Tenor Capital Management's LVAC Position: Q2 2023 in Review

Tenor Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 250,000 shares — an estimated $2.61M sold.

Tenor Capital Management first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $2.61M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Tenor Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Tenor Capital Management sold 250,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.61M.
Tenor Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Tenor Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.61M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Tenor Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.